Clinical Trials Browser

Phase 2 × Glioblastoma × camrelizumab × Clear all

NCT04952571 2024-10-15

Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)

Phase 2 Terminated

Glioblastoma

NCT04888611 2021-11-30

Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma

Phase 2 Unknown

Glioblastoma

NCT04583020 2020-11-30

Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma

Phase 2 Unknown

Glioblastoma